Status:

COMPLETED

Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System

Lead Sponsor:

Klick Inc.

Collaborating Sponsors:

Mittal Global Clinical Trial Services

Conditions:

Healthy

Type 2 Diabetes Mellitus

Eligibility:

All Genders

18-60 years

Brief Summary

Current gold standard methodologies for diagnosing type 2 diabetes (T2D) or prediabetes can be unreliable and inaccurate, and require the need for multiple different tests for comparison. It is possib...

Eligibility Criteria

Inclusion

  • Either male or non-pregnant, non-lactating female aged \> 18-60 \<years (both inclusive)
  • Subjects willing to give written informed consent
  • Healthy Volunteers
  • Subjects able to comply with the study protocol
  • Women of child bearing potential must have a negative urine pregnancy test prior to study entry
  • Minimum 4 subjects in each interval of approx 7 years (18-25/26-32/32-38/39-45/46-52/53-59)
  • Minimum 40% subjects of one gender to mark relative distribution

Exclusion

  • Any person below the age of 18 years
  • Suspected or confirmed pregnancy
  • Currently breastfeeding
  • Diagnosis of any known chronic or acute medical disease of any kind (e.g., cardiovascular disease, respiratory disease, influenza, pneumonia, etc.)
  • Diagnosis of any known neurological disease or psychological disorder of any kind (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.)
  • Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.)
  • Any form of prescription medication
  • Use of antibiotics in the three months prior to enrollment
  • Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study (as per restrictions of the FreeStyle Libre pro device)

Key Trial Info

Start Date :

August 31 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2022

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04529239

Start Date

August 31 2020

End Date

March 1 2022

Last Update

March 29 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Klick Inc.

Toronto, Ontario, Canada, M4W 3R8